age 1 of 64
NURS 615 EXAM 1 STUDY GUIDE 2025/2026
COMPLETE QUESTIONS WITH CORRECT DETAILED
ANSWERS || 100% GUARANTEED PASS <BRAND
NEW VERSION>
§ Dipeptidyl Peptidase-4 Inhibitor Adverse effects
.....Answer.....Hypoglycemia
Skin rash (steven's johnson's rash - serious!)
Arthralgia (joint pain)
Pancreatitis
Renal impairment and heart failure - use with caution in these
patients
GLP-1 receptor agonist Meds .....Answer.....Exenatide (Byetta)
,age 2 of 64
Dulaglutide (Trulicity)
Semaglutide (Ozempic/ *Rybelsus - this one is only ORAL med)
GLP-1 MOAs .....Answer.....Act as endogenous GLP-1
Long half life
Reduces:
Triglycerides
Systolic blood pressure
Weight
Glucose-dependent insulin secretion
Increased insulin synthesis
Increased beta cell mass via multiple mechanisms
,age 3 of 64
Suppression of glucagon secretion
Slowing of gastric emptying
Decreased appetite - reduction of nutrient intake and weight
loss
GLP-1 Adverse effects .....Answer.....GI - N/V
Gallbladder disease
Thyroid dysfunction
Pancreatitis or pancreatic duct metaplasia
Kidney failure/injury
GLP-1 Contraindications .....Answer.....Personal or family hx of
medullary thyroid carcinoma and and nocrine neoplasia
, age 4 of 64
Moderate or greater renal disease
History of GI disease
Med for HYPOthyroidism .....Answer.....Treated with
levothyroxine - acts like the body's endogenous thyroid hormone
Regulates metabolism, HR, Resp Rate
Levothyroxine adverse effects .....Answer.....Diarrhea
Weight loss
Cardiac arrythmias (elderly at risk, titrate SLOWLY)
Menstrual irregularity
Heat intolerance
Levothyroxine patient teaching on how to take .....Answer.....Take
on empty stomach, 30 mins or more before breakfast
NURS 615 EXAM 1 STUDY GUIDE 2025/2026
COMPLETE QUESTIONS WITH CORRECT DETAILED
ANSWERS || 100% GUARANTEED PASS <BRAND
NEW VERSION>
§ Dipeptidyl Peptidase-4 Inhibitor Adverse effects
.....Answer.....Hypoglycemia
Skin rash (steven's johnson's rash - serious!)
Arthralgia (joint pain)
Pancreatitis
Renal impairment and heart failure - use with caution in these
patients
GLP-1 receptor agonist Meds .....Answer.....Exenatide (Byetta)
,age 2 of 64
Dulaglutide (Trulicity)
Semaglutide (Ozempic/ *Rybelsus - this one is only ORAL med)
GLP-1 MOAs .....Answer.....Act as endogenous GLP-1
Long half life
Reduces:
Triglycerides
Systolic blood pressure
Weight
Glucose-dependent insulin secretion
Increased insulin synthesis
Increased beta cell mass via multiple mechanisms
,age 3 of 64
Suppression of glucagon secretion
Slowing of gastric emptying
Decreased appetite - reduction of nutrient intake and weight
loss
GLP-1 Adverse effects .....Answer.....GI - N/V
Gallbladder disease
Thyroid dysfunction
Pancreatitis or pancreatic duct metaplasia
Kidney failure/injury
GLP-1 Contraindications .....Answer.....Personal or family hx of
medullary thyroid carcinoma and and nocrine neoplasia
, age 4 of 64
Moderate or greater renal disease
History of GI disease
Med for HYPOthyroidism .....Answer.....Treated with
levothyroxine - acts like the body's endogenous thyroid hormone
Regulates metabolism, HR, Resp Rate
Levothyroxine adverse effects .....Answer.....Diarrhea
Weight loss
Cardiac arrythmias (elderly at risk, titrate SLOWLY)
Menstrual irregularity
Heat intolerance
Levothyroxine patient teaching on how to take .....Answer.....Take
on empty stomach, 30 mins or more before breakfast
